

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 8.85018083 |
| 2 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 8.26099188 |
| 3 | regulation of relaxation of muscle (GO:1901077) | 7.96952784 |
| 4 | potassium ion homeostasis (GO:0055075) | 7.93700709 |
| 5 | muscle filament sliding (GO:0030049) | 7.93484760 |
| 6 | actin-myosin filament sliding (GO:0033275) | 7.93484760 |
| 7 | regulation of actin filament-based movement (GO:1903115) | 7.80815251 |
| 8 | cardiac myofibril assembly (GO:0055003) | 7.75694479 |
| 9 | cardiac muscle contraction (GO:0060048) | 7.72431591 |
| 10 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 7.68146480 |
| 11 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 7.52936214 |
| 12 | myofibril assembly (GO:0030239) | 7.32750236 |
| 13 | regulation of cell communication by electrical coupling (GO:0010649) | 6.91733967 |
| 14 | cardiac muscle hypertrophy (GO:0003300) | 6.78398141 |
| 15 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.62410106 |
| 16 | actin-mediated cell contraction (GO:0070252) | 6.61056917 |
| 17 | hypotonic response (GO:0006971) | 6.48912543 |
| 18 | striated muscle hypertrophy (GO:0014897) | 6.41473244 |
| 19 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 6.24426917 |
| 20 | striated muscle contraction (GO:0006941) | 6.19933464 |
| 21 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 6.10420422 |
| 22 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.04145690 |
| 23 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.94351714 |
| 24 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.93583367 |
| 25 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.92432880 |
| 26 | cell communication involved in cardiac conduction (GO:0086065) | 5.84384253 |
| 27 | NADH metabolic process (GO:0006734) | 5.81990439 |
| 28 | regulation of cardiac muscle cell contraction (GO:0086004) | 5.80370452 |
| 29 | muscle hypertrophy (GO:0014896) | 5.77081527 |
| 30 | actomyosin structure organization (GO:0031032) | 5.75778022 |
| 31 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.73933660 |
| 32 | regulation of the force of heart contraction (GO:0002026) | 5.69433269 |
| 33 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.67271036 |
| 34 | adult heart development (GO:0007512) | 5.60239403 |
| 35 | cardiac muscle cell development (GO:0055013) | 5.59894587 |
| 36 | muscle tissue morphogenesis (GO:0060415) | 5.40340121 |
| 37 | regulation of striated muscle contraction (GO:0006942) | 5.32243380 |
| 38 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.23899204 |
| 39 | cardiac cell development (GO:0055006) | 5.19983150 |
| 40 | cell communication by electrical coupling (GO:0010644) | 5.15778316 |
| 41 | carnitine shuttle (GO:0006853) | 5.05333723 |
| 42 | heart process (GO:0003015) | 5.02594930 |
| 43 | heart contraction (GO:0060047) | 5.02594930 |
| 44 | sodium ion homeostasis (GO:0055078) | 5.01072620 |
| 45 | detection of calcium ion (GO:0005513) | 5.00432176 |
| 46 | actin filament-based movement (GO:0030048) | 4.89029194 |
| 47 | regulation of heart rate (GO:0002027) | 4.79240444 |
| 48 | response to inactivity (GO:0014854) | 4.76456464 |
| 49 | regulation of cardiac muscle contraction (GO:0055117) | 4.67688688 |
| 50 | regulation of membrane repolarization (GO:0060306) | 4.63428638 |
| 51 | relaxation of cardiac muscle (GO:0055119) | 4.55750191 |
| 52 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.52554708 |
| 53 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.49415095 |
| 54 | fatty acid transmembrane transport (GO:1902001) | 4.48426354 |
| 55 | creatine metabolic process (GO:0006600) | 4.41626352 |
| 56 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.41426148 |
| 57 | muscle hypertrophy in response to stress (GO:0003299) | 4.41426148 |
| 58 | cardiac muscle adaptation (GO:0014887) | 4.41426148 |
| 59 | cardiac muscle cell action potential (GO:0086001) | 4.39243508 |
| 60 | xenobiotic catabolic process (GO:0042178) | 4.36630731 |
| 61 | positive regulation of heart rate (GO:0010460) | 4.34017225 |
| 62 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.33445664 |
| 63 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 4.28034376 |
| 64 | regulation of ATP catabolic process (GO:1903289) | 4.24620254 |
| 65 | regulation of ATPase activity (GO:0043462) | 4.24620254 |
| 66 | extracellular matrix assembly (GO:0085029) | 4.20423939 |
| 67 | tricarboxylic acid cycle (GO:0006099) | 4.17094030 |
| 68 | tonic smooth muscle contraction (GO:0014820) | 4.10014012 |
| 69 | regulation of heart contraction (GO:0008016) | 4.08303576 |
| 70 | response to epinephrine (GO:0071871) | 4.07162414 |
| 71 | cellular response to epinephrine stimulus (GO:0071872) | 4.01921419 |
| 72 | muscle contraction (GO:0006936) | 3.98825813 |
| 73 | response to caffeine (GO:0031000) | 3.95522054 |
| 74 | regulation of sarcomere organization (GO:0060297) | 3.94820028 |
| 75 | carnitine transmembrane transport (GO:1902603) | 3.93310970 |
| 76 | positive regulation of action potential (GO:0045760) | 3.93022191 |
| 77 | skeletal muscle contraction (GO:0003009) | 3.88131720 |
| 78 | cardiac conduction (GO:0061337) | 3.87757615 |
| 79 | adrenergic receptor signaling pathway (GO:0071875) | 3.86790727 |
| 80 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.83177752 |
| 81 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.83177752 |
| 82 | sulfur amino acid catabolic process (GO:0000098) | 3.82624607 |
| 83 | regulation of cardioblast differentiation (GO:0051890) | 3.80853628 |
| 84 | cardiac chamber formation (GO:0003207) | 3.79577497 |
| 85 | glomerulus development (GO:0032835) | 3.78756399 |
| 86 | galactose metabolic process (GO:0006012) | 3.75799618 |
| 87 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.71532857 |
| 88 | carnitine transport (GO:0015879) | 3.70028739 |
| 89 | amino-acid betaine transport (GO:0015838) | 3.70028739 |
| 90 | tricarboxylic acid metabolic process (GO:0072350) | 3.69645684 |
| 91 | muscle system process (GO:0003012) | 3.68460312 |
| 92 | regulation of sequestering of triglyceride (GO:0010889) | 3.67946980 |
| 93 | cardiac ventricle formation (GO:0003211) | 3.67458312 |
| 94 | water transport (GO:0006833) | 3.63980697 |
| 95 | phenylpropanoid metabolic process (GO:0009698) | 3.61970381 |
| 96 | striated muscle adaptation (GO:0014888) | 3.57206016 |
| 97 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.57173472 |
| 98 | cell differentiation involved in metanephros development (GO:0072202) | 3.54773296 |
| 99 | positive regulation of heart contraction (GO:0045823) | 3.54037935 |
| 100 | regulation of muscle contraction (GO:0006937) | 3.53729210 |
| 101 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.49454088 |
| 102 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.45539664 |
| 103 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.45539664 |
| 104 | positive regulation of cation channel activity (GO:2001259) | 3.40981211 |
| 105 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.38886333 |
| 106 | positive regulation of sodium ion transport (GO:0010765) | 3.38348777 |
| 107 | regulation of muscle system process (GO:0090257) | 3.33325086 |
| 108 | protein autoprocessing (GO:0016540) | 3.33128051 |
| 109 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.31728051 |
| 110 | relaxation of muscle (GO:0090075) | 3.27044879 |
| 111 | glyoxylate metabolic process (GO:0046487) | 3.27023418 |
| 112 | 2-oxoglutarate metabolic process (GO:0006103) | 3.23925523 |
| 113 | regulation of cation channel activity (GO:2001257) | 3.23822288 |
| 114 | lung vasculature development (GO:0060426) | 3.19915842 |
| 115 | metanephric mesenchyme development (GO:0072075) | 3.14117506 |
| 116 | fluid transport (GO:0042044) | 3.13500850 |
| 117 | endocardial cushion morphogenesis (GO:0003203) | 3.13477638 |
| 118 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 3.12280675 |
| 119 | glucuronate metabolic process (GO:0019585) | 3.12174675 |
| 120 | uronic acid metabolic process (GO:0006063) | 3.12174675 |
| 121 | regulation of protein glycosylation (GO:0060049) | 3.10600120 |
| 122 | smooth muscle contraction (GO:0006939) | 3.08404621 |
| 123 | protein localization to cell surface (GO:0034394) | 2.98733451 |
| 124 | platelet aggregation (GO:0070527) | 2.98352349 |
| 125 | cellular response to osmotic stress (GO:0071470) | 2.96009974 |
| 126 | cGMP-mediated signaling (GO:0019934) | 2.91523573 |
| 127 | gap junction assembly (GO:0016264) | 2.89740702 |
| 128 | angiogenesis involved in wound healing (GO:0060055) | 2.80344860 |
| 129 | regulation of plasminogen activation (GO:0010755) | 2.78796698 |
| 130 | cellular modified amino acid catabolic process (GO:0042219) | 2.78158189 |
| 131 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.76312299 |
| 132 | L-ascorbic acid metabolic process (GO:0019852) | 2.74655078 |
| 133 | negative regulation of sodium ion transport (GO:0010766) | 2.73266813 |
| 134 | endocrine hormone secretion (GO:0060986) | 2.72814880 |
| 135 | kidney mesenchyme development (GO:0072074) | 2.71839205 |
| 136 | negative regulation of muscle hypertrophy (GO:0014741) | 2.70844478 |
| 137 | nephron epithelium morphogenesis (GO:0072088) | 2.68454166 |
| 138 | nephron tubule morphogenesis (GO:0072078) | 2.68454166 |
| 139 | regulation of skeletal muscle contraction (GO:0014819) | 2.68388343 |
| 140 | mesenchyme morphogenesis (GO:0072132) | 2.66698805 |
| 141 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.65761365 |
| 142 | ethanol metabolic process (GO:0006067) | 2.65534718 |
| 143 | protein heterotrimerization (GO:0070208) | 2.65313891 |
| 144 | protein retention in ER lumen (GO:0006621) | 2.64117941 |
| 145 | cellular glucuronidation (GO:0052695) | 2.62164503 |
| 146 | fucose catabolic process (GO:0019317) | 2.60451327 |
| 147 | L-fucose metabolic process (GO:0042354) | 2.60451327 |
| 148 | L-fucose catabolic process (GO:0042355) | 2.60451327 |
| 149 | N-glycan processing (GO:0006491) | 2.58549166 |
| 150 | camera-type eye morphogenesis (GO:0048593) | 2.58339372 |
| 151 | renal tubule morphogenesis (GO:0061333) | 2.57763801 |
| 152 | relaxation of smooth muscle (GO:0044557) | 2.55876753 |
| 153 | renal system development (GO:0072001) | 2.55587283 |
| 154 | regulation of cardiac muscle hypertrophy (GO:0010611) | 2.55216679 |
| 155 | metanephric nephron tubule development (GO:0072234) | 2.52302093 |
| 156 | metanephric tubule development (GO:0072170) | 2.52302093 |
| 157 | primary alcohol catabolic process (GO:0034310) | 2.51490639 |
| 158 | endothelial cell morphogenesis (GO:0001886) | 2.50216218 |
| 159 | galactose catabolic process (GO:0019388) | 2.49017475 |
| 160 | glutathione metabolic process (GO:0006749) | 2.48110221 |
| 161 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.47936940 |
| 162 | glutathione derivative biosynthetic process (GO:1901687) | 2.47339137 |
| 163 | glutathione derivative metabolic process (GO:1901685) | 2.47339137 |
| 164 | nephron epithelium development (GO:0072009) | 2.46945152 |
| 165 | regulation of synapse structural plasticity (GO:0051823) | 2.46833284 |
| 166 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.46576848 |
| 167 | negative regulation of heart growth (GO:0061117) | 2.46576848 |
| 168 | negative regulation of epidermal cell differentiation (GO:0045605) | 2.45222627 |
| 169 | spindle assembly involved in mitosis (GO:0090307) | 2.43714346 |
| 170 | negative regulation of embryonic development (GO:0045992) | 2.42122972 |
| 171 | regulation of muscle hypertrophy (GO:0014743) | 2.41983421 |
| 172 | stress fiber assembly (GO:0043149) | 2.39979908 |
| 173 | aldehyde catabolic process (GO:0046185) | 2.39704665 |
| 174 | benzene-containing compound metabolic process (GO:0042537) | 2.38629029 |
| 175 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.37541233 |
| 176 | nephron tubule development (GO:0072080) | 2.37485317 |
| 177 | respiratory tube development (GO:0030323) | 2.37397947 |
| 178 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.36752442 |
| 179 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.36512900 |
| 180 | cellular ketone body metabolic process (GO:0046950) | 2.35994918 |
| 181 | vascular smooth muscle contraction (GO:0014829) | 2.35727488 |
| 182 | polyol transport (GO:0015791) | 2.35155597 |
| 183 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.34153637 |
| 184 | vasoconstriction (GO:0042310) | 2.34147676 |
| 185 | homotypic cell-cell adhesion (GO:0034109) | 2.31667400 |
| 186 | endocardial cushion development (GO:0003197) | 2.30817510 |
| 187 | cysteine metabolic process (GO:0006534) | 2.28101569 |
| 188 | growth hormone secretion (GO:0030252) | 2.27993728 |
| 189 | midgut development (GO:0007494) | 2.27640367 |
| 190 | regulation of muscle adaptation (GO:0043502) | 2.27582657 |
| 191 | metanephric nephron epithelium development (GO:0072243) | 2.27436745 |
| 192 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.27124255 |
| 193 | lung morphogenesis (GO:0060425) | 2.26369865 |
| 194 | cell differentiation involved in kidney development (GO:0061005) | 2.25965298 |
| 195 | regulation of cholesterol homeostasis (GO:2000188) | 2.24170603 |
| 196 | early endosome to late endosome transport (GO:0045022) | 2.23993438 |
| 197 | one-carbon compound transport (GO:0019755) | 11.7779916 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 5.17589130 |
| 2 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 3.91665498 |
| 3 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.86246400 |
| 4 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 3.15110674 |
| 5 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.11744630 |
| 6 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.11744630 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.81145718 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.67056665 |
| 9 | VDR_22108803_ChIP-Seq_LS180_Human | 2.56770527 |
| 10 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.52900907 |
| 11 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.46945817 |
| 12 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.35220110 |
| 13 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.32524353 |
| 14 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.15268755 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.11907514 |
| 16 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.10067013 |
| 17 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.02550893 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.01372369 |
| 19 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.00904724 |
| 20 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.00817729 |
| 21 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.98286684 |
| 22 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.96962860 |
| 23 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.94492242 |
| 24 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.94106736 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.88136003 |
| 26 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.87863204 |
| 27 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.87863204 |
| 28 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.85826891 |
| 29 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.85518612 |
| 30 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.85424917 |
| 31 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.84918535 |
| 32 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.82467776 |
| 33 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.80294514 |
| 34 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.78449881 |
| 35 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.76432609 |
| 36 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.74784684 |
| 37 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.73458173 |
| 38 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.72164375 |
| 39 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.71714646 |
| 40 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.69114432 |
| 41 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.68604290 |
| 42 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.67877558 |
| 43 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.65428093 |
| 44 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.61733624 |
| 45 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.61322925 |
| 46 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.55050178 |
| 47 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.54959536 |
| 48 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.52404695 |
| 49 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51756108 |
| 50 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.50330948 |
| 51 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.48548327 |
| 52 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.46996739 |
| 53 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.46054334 |
| 54 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.44776839 |
| 55 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.44776839 |
| 56 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.40921318 |
| 57 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.40130783 |
| 58 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.39932738 |
| 59 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.39079274 |
| 60 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.39040008 |
| 61 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.38429922 |
| 62 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.36058845 |
| 63 | CJUN_26792858_Chip-Seq_BT549_Human | 1.35844236 |
| 64 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.35664743 |
| 65 | TP53_16413492_ChIP-PET_HCT116_Human | 1.32570231 |
| 66 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.31424270 |
| 67 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.31124740 |
| 68 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.30988335 |
| 69 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30473562 |
| 70 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.30379929 |
| 71 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.30190259 |
| 72 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.27487931 |
| 73 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.26394931 |
| 74 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.25337652 |
| 75 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.23882026 |
| 76 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.23435045 |
| 77 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.22659744 |
| 78 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.20963737 |
| 79 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.20679878 |
| 80 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.18096216 |
| 81 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.17243087 |
| 82 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.16291980 |
| 83 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.15831236 |
| 84 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.15188400 |
| 85 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.12971698 |
| 86 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.12669653 |
| 87 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.12489451 |
| 88 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.12332690 |
| 89 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.11331550 |
| 90 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.10910819 |
| 91 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09396263 |
| 92 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09033843 |
| 93 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.08962877 |
| 94 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.08934123 |
| 95 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.05101711 |
| 96 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.04887592 |
| 97 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.03931513 |
| 98 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.03582515 |
| 99 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.02945601 |
| 100 | KDM2B_26808549_Chip-Seq_K562_Human | 1.02815047 |
| 101 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.02770061 |
| 102 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.02576660 |
| 103 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.02503144 |
| 104 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.01443699 |
| 105 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00870639 |
| 106 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00482121 |
| 107 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.99582213 |
| 108 | TBL1_22424771_ChIP-Seq_293T_Human | 0.99562375 |
| 109 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.98551199 |
| 110 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.98513639 |
| 111 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.97521527 |
| 112 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.97516231 |
| 113 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97455091 |
| 114 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.97422698 |
| 115 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.97366062 |
| 116 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.97185620 |
| 117 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.96402563 |
| 118 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.96340421 |
| 119 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.95652555 |
| 120 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.95592418 |
| 121 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.95570125 |
| 122 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.95208227 |
| 123 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.95097354 |
| 124 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.94649508 |
| 125 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94441034 |
| 126 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.93920601 |
| 127 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.93515135 |
| 128 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.93110648 |
| 129 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.93076247 |
| 130 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.92109590 |
| 131 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.91702577 |
| 132 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.91501014 |
| 133 | STAT3_23295773_ChIP-Seq_U87_Human | 0.91035890 |
| 134 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.89717328 |
| 135 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.89548749 |
| 136 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.89480341 |
| 137 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.89186737 |
| 138 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.88200401 |
| 139 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87972404 |
| 140 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.87955438 |
| 141 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.87620008 |
| 142 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.86287087 |
| 143 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.86259137 |
| 144 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86198436 |
| 145 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.86159490 |
| 146 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.84139675 |
| 147 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.83999096 |
| 148 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.83813570 |
| 149 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.83667935 |
| 150 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.83572704 |
| 151 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.83540319 |
| 152 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.83460569 |
| 153 | NFYB_21822215_ChIP-Seq_K562_Human | 0.83233926 |
| 154 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.83163892 |
| 155 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82236614 |
| 156 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.82182059 |
| 157 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.82156643 |
| 158 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.81723774 |
| 159 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.81538077 |
| 160 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.81058547 |
| 161 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.80827659 |
| 162 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.80280072 |
| 163 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.79995135 |
| 164 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.79924927 |
| 165 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.79553397 |
| 166 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.79390809 |
| 167 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.79330480 |
| 168 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.79081688 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010386_abnormal_urinary_bladder | 8.71069847 |
| 2 | MP0005367_renal/urinary_system_phenotyp | 8.63759278 |
| 3 | MP0000516_abnormal_urinary_system | 8.63759278 |
| 4 | MP0004084_abnormal_cardiac_muscle | 6.39667013 |
| 5 | MP0004215_abnormal_myocardial_fiber | 5.03263218 |
| 6 | MP0003646_muscle_fatigue | 4.19367520 |
| 7 | MP0000534_abnormal_ureter_morphology | 3.99536268 |
| 8 | MP0000749_muscle_degeneration | 3.72986463 |
| 9 | MP0004510_myositis | 3.59373534 |
| 10 | MP0004484_altered_response_of | 3.48574612 |
| 11 | MP0001756_abnormal_urination | 3.41389064 |
| 12 | MP0008775_abnormal_heart_ventricle | 3.13208270 |
| 13 | MP0004087_abnormal_muscle_fiber | 3.00675350 |
| 14 | MP0006138_congestive_heart_failure | 2.88279319 |
| 15 | MP0004145_abnormal_muscle_electrophysio | 2.81010816 |
| 16 | MP0005385_cardiovascular_system_phenoty | 2.80493296 |
| 17 | MP0001544_abnormal_cardiovascular_syste | 2.80493296 |
| 18 | MP0003137_abnormal_impulse_conducting | 2.79840874 |
| 19 | MP0005423_abnormal_somatic_nervous | 2.59254828 |
| 20 | MP0010630_abnormal_cardiac_muscle | 2.55722789 |
| 21 | MP0001958_emphysema | 2.55581960 |
| 22 | MP0004130_abnormal_muscle_cell | 2.47541831 |
| 23 | MP0002106_abnormal_muscle_physiology | 2.46354022 |
| 24 | MP0000013_abnormal_adipose_tissue | 2.39280089 |
| 25 | MP0001986_abnormal_taste_sensitivity | 2.23255982 |
| 26 | MP0008438_abnormal_cutaneous_collagen | 2.22614244 |
| 27 | MP0002127_abnormal_cardiovascular_syste | 2.22024715 |
| 28 | MP0002269_muscular_atrophy | 2.19736979 |
| 29 | MP0000462_abnormal_digestive_system | 2.10699144 |
| 30 | MP0002822_catalepsy | 2.02092641 |
| 31 | MP0005369_muscle_phenotype | 2.00240206 |
| 32 | MP0002837_dystrophic_cardiac_calcinosis | 1.94691995 |
| 33 | MP0005165_increased_susceptibility_to | 1.92395422 |
| 34 | MP0000747_muscle_weakness | 1.88422969 |
| 35 | MP0000759_abnormal_skeletal_muscle | 1.76737350 |
| 36 | MP0002332_abnormal_exercise_endurance | 1.74325609 |
| 37 | MP0005623_abnormal_meninges_morphology | 1.65259886 |
| 38 | MP0010030_abnormal_orbit_morphology | 1.61406881 |
| 39 | MP0005275_abnormal_skin_tensile | 1.50848691 |
| 40 | MP0009643_abnormal_urine_homeostasis | 1.47791787 |
| 41 | MP0000538_abnormal_urinary_bladder | 1.43876972 |
| 42 | MP0005332_abnormal_amino_acid | 1.43189835 |
| 43 | MP0003828_pulmonary_edema | 1.43147818 |
| 44 | MP0001664_abnormal_digestion | 1.40579145 |
| 45 | MP0000230_abnormal_systemic_arterial | 1.38468447 |
| 46 | MP0003279_aneurysm | 1.35916282 |
| 47 | MP0004272_abnormal_basement_membrane | 1.32001981 |
| 48 | MP0006036_abnormal_mitochondrial_physio | 1.31911054 |
| 49 | MP0003221_abnormal_cardiomyocyte_apopto | 1.30537630 |
| 50 | MP0003252_abnormal_bile_duct | 1.22097574 |
| 51 | MP0000751_myopathy | 1.20502810 |
| 52 | MP0005503_abnormal_tendon_morphology | 1.16011678 |
| 53 | MP0005620_abnormal_muscle_contractility | 1.11870747 |
| 54 | MP0002136_abnormal_kidney_physiology | 1.09763812 |
| 55 | MP0005330_cardiomyopathy | 1.07742476 |
| 56 | MP0005164_abnormal_response_to | 1.03598385 |
| 57 | MP0005266_abnormal_metabolism | 1.02961811 |
| 58 | MP0001765_abnormal_ion_homeostasis | 1.02027873 |
| 59 | MP0004233_abnormal_muscle_weight | 1.01666662 |
| 60 | MP0003566_abnormal_cell_adhesion | 1.01387942 |
| 61 | MP0000266_abnormal_heart_morphology | 0.99487581 |
| 62 | MP0005023_abnormal_wound_healing | 0.99008835 |
| 63 | MP0005666_abnormal_adipose_tissue | 0.98262125 |
| 64 | MP0002108_abnormal_muscle_morphology | 0.96684146 |
| 65 | MP0005451_abnormal_body_composition | 0.93576799 |
| 66 | MP0001270_distended_abdomen | 0.90107088 |
| 67 | MP0004043_abnormal_pH_regulation | 0.87624450 |
| 68 | MP0010368_abnormal_lymphatic_system | 0.87482751 |
| 69 | MP0003705_abnormal_hypodermis_morpholog | 0.84083812 |
| 70 | MP0003950_abnormal_plasma_membrane | 0.81388830 |
| 71 | MP0002735_abnormal_chemical_nociception | 0.80811063 |
| 72 | MP0003283_abnormal_digestive_organ | 0.80676823 |
| 73 | MP0000003_abnormal_adipose_tissue | 0.78910128 |
| 74 | MP0008004_abnormal_stomach_pH | 0.78783940 |
| 75 | MP0006054_spinal_hemorrhage | 0.78737976 |
| 76 | MP0005595_abnormal_vascular_smooth | 0.77938671 |
| 77 | MP0001661_extended_life_span | 0.76287350 |
| 78 | MP0005360_urolithiasis | 0.76139339 |
| 79 | MP0000343_altered_response_to | 0.75644981 |
| 80 | MP0008875_abnormal_xenobiotic_pharmacok | 0.74918549 |
| 81 | MP0005381_digestive/alimentary_phenotyp | 0.74804064 |
| 82 | MP0002249_abnormal_larynx_morphology | 0.74593577 |
| 83 | MP0004858_abnormal_nervous_system | 0.74315358 |
| 84 | MP0002282_abnormal_trachea_morphology | 0.71553438 |
| 85 | MP0004883_abnormal_blood_vessel | 0.71501506 |
| 86 | MP0003385_abnormal_body_wall | 0.71081566 |
| 87 | MP0002128_abnormal_blood_circulation | 0.70013020 |
| 88 | MP0002135_abnormal_kidney_morphology | 0.68457932 |
| 89 | MP0004036_abnormal_muscle_relaxation | 0.68293069 |
| 90 | MP0003045_fibrosis | 0.68239427 |
| 91 | MP0003878_abnormal_ear_physiology | 0.68029282 |
| 92 | MP0005377_hearing/vestibular/ear_phenot | 0.68029282 |
| 93 | MP0004019_abnormal_vitamin_homeostasis | 0.67783855 |
| 94 | MP0009840_abnormal_foam_cell | 0.66291339 |
| 95 | MP0001346_abnormal_lacrimal_gland | 0.66175001 |
| 96 | MP0002139_abnormal_hepatobiliary_system | 0.65463240 |
| 97 | MP0004885_abnormal_endolymph | 0.64653853 |
| 98 | MP0002971_abnormal_brown_adipose | 0.62986426 |
| 99 | MP0002009_preneoplasia | 0.62928517 |
| 100 | MP0005197_abnormal_uvea_morphology | 0.62473913 |
| 101 | MP0002166_altered_tumor_susceptibility | 0.62350452 |
| 102 | MP0004859_abnormal_synaptic_plasticity | 0.61076276 |
| 103 | MP0003191_abnormal_cellular_cholesterol | 0.59108450 |
| 104 | MP0005508_abnormal_skeleton_morphology | 0.54803869 |
| 105 | MP0003567_abnormal_fetal_cardiomyocyte | 0.54261586 |
| 106 | MP0009780_abnormal_chondrocyte_physiolo | 0.53982306 |
| 107 | MP0002234_abnormal_pharynx_morphology | 0.53815297 |
| 108 | MP0002896_abnormal_bone_mineralization | 0.53768089 |
| 109 | MP0002928_abnormal_bile_duct | 0.52840386 |
| 110 | MP0001879_abnormal_lymphatic_vessel | 0.52673235 |
| 111 | MP0000733_abnormal_muscle_development | 0.51386517 |
| 112 | MP0005670_abnormal_white_adipose | 0.50342186 |
| 113 | MP0001299_abnormal_eye_distance/ | 0.50144004 |
| 114 | MP0005085_abnormal_gallbladder_physiolo | 0.50039093 |
| 115 | MP0005319_abnormal_enzyme/_coenzyme | 0.49889256 |
| 116 | MP0002060_abnormal_skin_morphology | 0.49264039 |
| 117 | MP0000613_abnormal_salivary_gland | 0.49069918 |
| 118 | MP0002909_abnormal_adrenal_gland | 0.49000601 |
| 119 | MP0003300_gastrointestinal_ulcer | 0.48998484 |
| 120 | MP0000163_abnormal_cartilage_morphology | 0.48935407 |
| 121 | MP0003186_abnormal_redox_activity | 0.47804721 |
| 122 | MP0002653_abnormal_ependyma_morphology | 0.47791002 |
| 123 | MP0003638_abnormal_response/metabolism_ | 0.47091502 |
| 124 | MP0005375_adipose_tissue_phenotype | 0.47022844 |
| 125 | MP0004924_abnormal_behavior | 0.45363882 |
| 126 | MP0005386_behavior/neurological_phenoty | 0.45363882 |
| 127 | MP0009384_cardiac_valve_regurgitation | 0.45337177 |
| 128 | MP0005365_abnormal_bile_salt | 0.44320687 |
| 129 | MP0005535_abnormal_body_temperature | 0.43338967 |
| 130 | MP0002638_abnormal_pupillary_reflex | 0.43303622 |
| 131 | MP0010352_gastrointestinal_tract_polyps | 0.43066827 |
| 132 | MP0002078_abnormal_glucose_homeostasis | 0.43010574 |
| 133 | MP0001984_abnormal_olfaction | 0.42877594 |
| 134 | MP0006072_abnormal_retinal_apoptosis | 0.42807352 |
| 135 | MP0005187_abnormal_penis_morphology | 0.42764901 |
| 136 | MP0003122_maternal_imprinting | 0.42755467 |
| 137 | MP0009115_abnormal_fat_cell | 0.42035870 |
| 138 | MP0000537_abnormal_urethra_morphology | 0.41623404 |
| 139 | MP0002972_abnormal_cardiac_muscle | 0.41408460 |
| 140 | MP0004742_abnormal_vestibular_system | 0.40456136 |
| 141 | MP0002796_impaired_skin_barrier | 0.40061452 |
| 142 | MP0009250_abnormal_appendicular_skeleto | 0.39956229 |
| 143 | MP0000249_abnormal_blood_vessel | 0.39876696 |
| 144 | MP0005636_abnormal_mineral_homeostasis | 0.39684207 |
| 145 | MP0005166_decreased_susceptibility_to | 0.39667415 |
| 146 | MP0003942_abnormal_urinary_system | 0.39011542 |
| 147 | MP0003938_abnormal_ear_development | 0.38762957 |
| 148 | MP0005409_darkened_coat_color | 0.38700333 |
| 149 | MP0005334_abnormal_fat_pad | 0.38584838 |
| 150 | MP0008569_lethality_at_weaning | 0.38572155 |
| 151 | MP0000750_abnormal_muscle_regeneration | 0.38568067 |
| 152 | MP0004085_abnormal_heartbeat | 0.38420428 |
| 153 | MP0004147_increased_porphyrin_level | 0.36970922 |
| 154 | MP0002295_abnormal_pulmonary_circulatio | 0.36713623 |
| 155 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.36485276 |
| 156 | MP0002118_abnormal_lipid_homeostasis | 0.35461484 |
| 157 | MP0006035_abnormal_mitochondrial_morpho | 0.32988421 |
| 158 | MP0000767_abnormal_smooth_muscle | 0.32830355 |
| 159 | MP0005376_homeostasis/metabolism_phenot | 0.30958406 |
| 160 | MP0005167_abnormal_blood-brain_barrier | 0.26794967 |
| 161 | MP0004270_analgesia | 0.25883808 |
| 162 | MP0002876_abnormal_thyroid_physiology | 0.22887122 |
| 163 | MP0003136_yellow_coat_color | 0.20785170 |
| 164 | MP0003948_abnormal_gas_homeostasis | 0.19762766 |
| 165 | MP0001501_abnormal_sleep_pattern | 0.19756756 |
| 166 | MP0003183_abnormal_peptide_metabolism | 0.18911568 |
| 167 | MP0003879_abnormal_hair_cell | 0.18776372 |
| 168 | MP0001784_abnormal_fluid_regulation | 0.18323862 |
| 169 | MP0001666_abnormal_nutrient_absorption | 0.17366916 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 9.25198895 |
| 2 | Aortic aneurysm (HP:0004942) | 9.07264614 |
| 3 | Bundle branch block (HP:0011710) | 8.58877232 |
| 4 | Aortic dissection (HP:0002647) | 8.18530599 |
| 5 | Ventricular tachycardia (HP:0004756) | 6.81738694 |
| 6 | Atrial fibrillation (HP:0005110) | 6.34958393 |
| 7 | Syncope (HP:0001279) | 5.99393993 |
| 8 | Abnormality of the calf musculature (HP:0001430) | 5.81146719 |
| 9 | Primary atrial arrhythmia (HP:0001692) | 5.77870044 |
| 10 | Lipoatrophy (HP:0100578) | 5.67614141 |
| 11 | Supraventricular tachycardia (HP:0004755) | 5.57254753 |
| 12 | Asymmetric septal hypertrophy (HP:0001670) | 5.53776269 |
| 13 | Gastrointestinal dysmotility (HP:0002579) | 5.45711631 |
| 14 | Supraventricular arrhythmia (HP:0005115) | 5.41597862 |
| 15 | Calf muscle hypertrophy (HP:0008981) | 5.39582928 |
| 16 | Neoplasm of the heart (HP:0100544) | 5.31463555 |
| 17 | Malnutrition (HP:0004395) | 5.29405227 |
| 18 | Heart block (HP:0012722) | 5.26578984 |
| 19 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.12169274 |
| 20 | EMG: myopathic abnormalities (HP:0003458) | 5.09132453 |
| 21 | Dilated cardiomyopathy (HP:0001644) | 5.06353062 |
| 22 | Abnormal atrioventricular conduction (HP:0005150) | 4.93752357 |
| 23 | Ventricular arrhythmia (HP:0004308) | 4.91798929 |
| 24 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.83447949 |
| 25 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.80694838 |
| 26 | Subaortic stenosis (HP:0001682) | 4.80694838 |
| 27 | Muscle fiber inclusion bodies (HP:0100299) | 4.78758912 |
| 28 | Nemaline bodies (HP:0003798) | 4.63910373 |
| 29 | Aortic regurgitation (HP:0001659) | 4.39963751 |
| 30 | Palpitations (HP:0001962) | 4.39737390 |
| 31 | Ventricular fibrillation (HP:0001663) | 4.39294912 |
| 32 | Cerebral aneurysm (HP:0004944) | 4.24293886 |
| 33 | Atrioventricular block (HP:0001678) | 4.24101635 |
| 34 | Ankle contracture (HP:0006466) | 4.10033760 |
| 35 | Dilatation of the ascending aorta (HP:0005111) | 4.00320874 |
| 36 | Exercise-induced myalgia (HP:0003738) | 3.88526533 |
| 37 | Neck muscle weakness (HP:0000467) | 3.85621785 |
| 38 | Exercise-induced muscle cramps (HP:0003710) | 3.84073164 |
| 39 | EMG: neuropathic changes (HP:0003445) | 3.83607215 |
| 40 | Myoglobinuria (HP:0002913) | 3.80866657 |
| 41 | Short hallux (HP:0010109) | 3.73928764 |
| 42 | Hydroureter (HP:0000072) | 3.72267455 |
| 43 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.65222359 |
| 44 | Absent frontal sinuses (HP:0002688) | 3.59365738 |
| 45 | Rimmed vacuoles (HP:0003805) | 3.52582266 |
| 46 | Ragged-red muscle fibers (HP:0003200) | 3.51505258 |
| 47 | Abdominal situs inversus (HP:0003363) | 3.50032238 |
| 48 | Abnormality of abdominal situs (HP:0011620) | 3.50032238 |
| 49 | Aneurysm (HP:0002617) | 3.49983434 |
| 50 | Abnormal pupillary function (HP:0007686) | 3.49566548 |
| 51 | Ulnar bowing (HP:0003031) | 3.42842183 |
| 52 | Rhabdomyolysis (HP:0003201) | 3.42303782 |
| 53 | Left ventricular hypertrophy (HP:0001712) | 3.40037252 |
| 54 | Increased density of long bones (HP:0006392) | 3.34534522 |
| 55 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 3.33973553 |
| 56 | Long toe (HP:0010511) | 3.32888713 |
| 57 | Spastic diplegia (HP:0001264) | 3.23166327 |
| 58 | Stridor (HP:0010307) | 3.20823672 |
| 59 | Prolonged QT interval (HP:0001657) | 3.13790890 |
| 60 | Areflexia of lower limbs (HP:0002522) | 3.13147719 |
| 61 | Difficulty running (HP:0009046) | 3.10481263 |
| 62 | Short 4th metacarpal (HP:0010044) | 3.09147418 |
| 63 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 3.09147418 |
| 64 | Persistence of primary teeth (HP:0006335) | 3.01386900 |
| 65 | Scapular winging (HP:0003691) | 2.99834902 |
| 66 | Mesomelia (HP:0003027) | 2.94334621 |
| 67 | Abnormality of the foot musculature (HP:0001436) | 2.94271884 |
| 68 | Broad distal phalanx of finger (HP:0009836) | 2.93483608 |
| 69 | Abnormal EKG (HP:0003115) | 2.93021230 |
| 70 | Wrist flexion contracture (HP:0001239) | 2.87511214 |
| 71 | Arterial tortuosity (HP:0005116) | 2.86598536 |
| 72 | Bicuspid aortic valve (HP:0001647) | 2.85679845 |
| 73 | Abnormality of oral frenula (HP:0000190) | 2.79584192 |
| 74 | Vascular tortuosity (HP:0004948) | 2.79102426 |
| 75 | Facial diplegia (HP:0001349) | 2.78150278 |
| 76 | Osteolytic defects of the hand bones (HP:0009699) | 2.77133038 |
| 77 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.77133038 |
| 78 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.73744492 |
| 79 | Abnormal foot bone ossification (HP:0010675) | 2.71883360 |
| 80 | Generalized muscle weakness (HP:0003324) | 2.67854709 |
| 81 | Type 1 muscle fiber predominance (HP:0003803) | 2.62205957 |
| 82 | Hyperparathyroidism (HP:0000843) | 2.61671587 |
| 83 | Stroke (HP:0001297) | 2.58697074 |
| 84 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.57825456 |
| 85 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.57064133 |
| 86 | Radial bowing (HP:0002986) | 2.56352086 |
| 87 | Camptodactyly of toe (HP:0001836) | 2.55703969 |
| 88 | Palmoplantar keratoderma (HP:0000982) | 2.55164674 |
| 89 | Abnormality of the 2nd finger (HP:0004100) | 2.52543317 |
| 90 | Sudden cardiac death (HP:0001645) | 2.50564016 |
| 91 | Broad face (HP:0000283) | 2.49101344 |
| 92 | Foot dorsiflexor weakness (HP:0009027) | 2.48551762 |
| 93 | Pulmonary artery stenosis (HP:0004415) | 2.48287335 |
| 94 | Premature rupture of membranes (HP:0001788) | 2.41760876 |
| 95 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.41496830 |
| 96 | Right ventricular cardiomyopathy (HP:0011663) | 2.38420560 |
| 97 | Abnormality of the calcaneus (HP:0008364) | 2.38231659 |
| 98 | Tarsal synostosis (HP:0008368) | 2.38027640 |
| 99 | Frequent falls (HP:0002359) | 2.36832110 |
| 100 | Shawl scrotum (HP:0000049) | 2.36781392 |
| 101 | Back pain (HP:0003418) | 2.34293706 |
| 102 | Abnormality of the right ventricle (HP:0001707) | 2.33247040 |
| 103 | Distal lower limb amyotrophy (HP:0008944) | 2.28131790 |
| 104 | Elbow flexion contracture (HP:0002987) | 2.26810318 |
| 105 | Abnormality of the 4th metacarpal (HP:0010012) | 2.25782949 |
| 106 | Soft skin (HP:0000977) | 2.21658216 |
| 107 | Abnormal ossification of hand bones (HP:0005921) | 2.20081936 |
| 108 | Increased mean platelet volume (HP:0011877) | 2.19684810 |
| 109 | Bowing of the arm (HP:0006488) | 2.19167651 |
| 110 | Bowed forearm bones (HP:0003956) | 2.19167651 |
| 111 | Ureteral stenosis (HP:0000071) | 2.18404551 |
| 112 | Synostosis involving bones of the lower limbs (HP:0009138) | 2.17921769 |
| 113 | Synostosis involving bones of the feet (HP:0009140) | 2.17921769 |
| 114 | Long foot (HP:0001833) | 2.12403025 |
| 115 | Selective tooth agenesis (HP:0001592) | 2.09289402 |
| 116 | Difficulty climbing stairs (HP:0003551) | 2.04229929 |
| 117 | Arachnodactyly (HP:0001166) | 2.04154900 |
| 118 | Abnormality of the tricuspid valve (HP:0001702) | 2.03934233 |
| 119 | Steppage gait (HP:0003376) | 2.02034493 |
| 120 | Ureteral obstruction (HP:0006000) | 2.01934559 |
| 121 | Muscular dystrophy (HP:0003560) | 1.98952192 |
| 122 | Muscle fiber splitting (HP:0003555) | 1.98044805 |
| 123 | Congestive heart failure (HP:0001635) | 1.95097278 |
| 124 | Knee flexion contracture (HP:0006380) | 1.95069729 |
| 125 | Broad metatarsal (HP:0001783) | 1.94616710 |
| 126 | Increased intramyocellular lipid droplets (HP:0012240) | 1.94356085 |
| 127 | Spinal rigidity (HP:0003306) | 1.93419503 |
| 128 | Submucous cleft hard palate (HP:0000176) | 1.93279592 |
| 129 | Bulbar palsy (HP:0001283) | 1.92933427 |
| 130 | Increased muscle lipid content (HP:0009058) | 1.90905600 |
| 131 | Increased variability in muscle fiber diameter (HP:0003557) | 1.90823956 |
| 132 | Wormian bones (HP:0002645) | 1.89565779 |
| 133 | Hypoplastic left heart (HP:0004383) | 1.89176144 |
| 134 | Dysmetric saccades (HP:0000641) | 1.88329682 |
| 135 | Myopathic facies (HP:0002058) | 1.87676728 |
| 136 | Limb-girdle muscle atrophy (HP:0003797) | 1.87200079 |
| 137 | Abnormality of the odontoid process (HP:0003310) | 1.87058015 |
| 138 | Hyporeflexia of lower limbs (HP:0002600) | 1.86826840 |
| 139 | Increased serum pyruvate (HP:0003542) | 1.86700476 |
| 140 | Myotonia (HP:0002486) | 1.86133097 |
| 141 | Hand muscle atrophy (HP:0009130) | 1.84516758 |
| 142 | Toxemia of pregnancy (HP:0100603) | 1.84300143 |
| 143 | Gowers sign (HP:0003391) | 1.83844594 |
| 144 | Abnormal cartilage morphology (HP:0002763) | 1.83416679 |
| 145 | Bradycardia (HP:0001662) | 1.82806752 |
| 146 | Abnormal platelet volume (HP:0011876) | 1.82462389 |
| 147 | Fragile skin (HP:0001030) | 1.82289584 |
| 148 | Joint contractures involving the joints of the feet (HP:0100492) | 1.81931631 |
| 149 | Flexion contracture of toe (HP:0005830) | 1.81931631 |
| 150 | Mitral valve prolapse (HP:0001634) | 1.81872289 |
| 151 | Protrusio acetabuli (HP:0003179) | 1.81637239 |
| 152 | Proximal amyotrophy (HP:0007126) | 1.80991597 |
| 153 | Abnormality of the frontal sinuses (HP:0002687) | 1.80197015 |
| 154 | Hyperglycinuria (HP:0003108) | 1.76422145 |
| 155 | Progressive muscle weakness (HP:0003323) | 1.76011301 |
| 156 | Carpal synostosis (HP:0009702) | 1.74743750 |
| 157 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.73753773 |
| 158 | Peritonitis (HP:0002586) | 1.73567108 |
| 159 | Distal arthrogryposis (HP:0005684) | 1.72158050 |
| 160 | Distal upper limb amyotrophy (HP:0007149) | 1.71402293 |
| 161 | Upper limb amyotrophy (HP:0009129) | 1.71402293 |
| 162 | Increased connective tissue (HP:0009025) | 1.71090072 |
| 163 | Distal lower limb muscle weakness (HP:0009053) | 1.70716759 |
| 164 | Abnormality of glycolysis (HP:0004366) | 1.69713379 |
| 165 | Skin nodule (HP:0200036) | 1.69473705 |
| 166 | Congenital malformation of the right heart (HP:0011723) | 1.68462105 |
| 167 | Double outlet right ventricle (HP:0001719) | 1.68462105 |
| 168 | Spontaneous abortion (HP:0005268) | 1.67117522 |
| 169 | Lower limb amyotrophy (HP:0007210) | 1.65402705 |
| 170 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.65396771 |
| 171 | Femoral bowing (HP:0002980) | 1.61637141 |
| 172 | Omphalocele (HP:0001539) | 1.61527720 |
| 173 | Hypoplastic heart (HP:0001961) | 1.61051755 |
| 174 | Exercise intolerance (HP:0003546) | 1.60809761 |
| 175 | Fused cervical vertebrae (HP:0002949) | 1.59541684 |
| 176 | Absent toe (HP:0010760) | 1.59326634 |
| 177 | Abnormality of the endocardium (HP:0004306) | 1.53010216 |
| 178 | Late onset (HP:0003584) | 1.47941906 |
| 179 | Central scotoma (HP:0000603) | 1.45801480 |
| 180 | Round ear (HP:0100830) | 1.42534564 |
| 181 | Hepatic necrosis (HP:0002605) | 1.42306045 |
| 182 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.42013221 |
| 183 | Oligomenorrhea (HP:0000876) | 1.40067674 |
| 184 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.38926506 |
| 185 | Childhood onset (HP:0011463) | 1.37260075 |
| 186 | Progressive external ophthalmoplegia (HP:0000590) | 1.36436436 |
| 187 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.35804149 |
| 188 | Muscle stiffness (HP:0003552) | 1.31656039 |
| 189 | Hyperkalemia (HP:0002153) | 1.31560168 |
| 190 | Weak cry (HP:0001612) | 1.31494028 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 8.22901866 |
| 2 | MYLK | 8.05666830 |
| 3 | OBSCN | 7.80072485 |
| 4 | DMPK | 2.92690414 |
| 5 | PAK2 | 2.65803886 |
| 6 | MST1R | 2.46818064 |
| 7 | MAPKAPK3 | 2.44221824 |
| 8 | PIK3CG | 2.38642787 |
| 9 | RIPK1 | 2.25612149 |
| 10 | EPHB2 | 2.24107294 |
| 11 | MUSK | 2.15974204 |
| 12 | PINK1 | 2.04350901 |
| 13 | DDR2 | 1.91117279 |
| 14 | MINK1 | 1.88302578 |
| 15 | ERN1 | 1.69976542 |
| 16 | LMTK2 | 1.69858831 |
| 17 | AKT3 | 1.69078475 |
| 18 | MARK1 | 1.65083576 |
| 19 | STK4 | 1.47480718 |
| 20 | NEK9 | 1.43039593 |
| 21 | EPHA3 | 1.42814332 |
| 22 | GRK7 | 1.40757415 |
| 23 | PRKAA2 | 1.35440959 |
| 24 | EEF2K | 1.33135844 |
| 25 | BLK | 1.26036119 |
| 26 | CAMK2G | 1.23188103 |
| 27 | OXSR1 | 1.19135631 |
| 28 | PRKAA1 | 1.15898762 |
| 29 | TRPM7 | 1.15184555 |
| 30 | TIE1 | 1.14080966 |
| 31 | STK39 | 1.13881763 |
| 32 | WNK4 | 1.13858809 |
| 33 | RPS6KA2 | 1.06452469 |
| 34 | RPS6KB2 | 1.06021117 |
| 35 | STK24 | 1.05823656 |
| 36 | MAP3K6 | 1.03511688 |
| 37 | ILK | 1.02837683 |
| 38 | DAPK3 | 1.01829405 |
| 39 | MAP2K3 | 1.00641823 |
| 40 | TGFBR2 | 0.98557957 |
| 41 | CAMK4 | 0.98473293 |
| 42 | EPHA2 | 0.97806125 |
| 43 | ROCK1 | 0.96638536 |
| 44 | PRKCE | 0.95903563 |
| 45 | PAK3 | 0.95191087 |
| 46 | LATS2 | 0.93553127 |
| 47 | LIMK1 | 0.91644021 |
| 48 | PAK1 | 0.90708751 |
| 49 | CDC42BPA | 0.87052384 |
| 50 | PIK3CA | 0.83237114 |
| 51 | MET | 0.82266222 |
| 52 | PDGFRA | 0.82012466 |
| 53 | NME2 | 0.81130336 |
| 54 | CAMK1G | 0.80414856 |
| 55 | NEK1 | 0.79645687 |
| 56 | CAMK2D | 0.74060987 |
| 57 | CLK1 | 0.73775794 |
| 58 | MAP3K5 | 0.73419190 |
| 59 | PHKG1 | 0.71565322 |
| 60 | PHKG2 | 0.71565322 |
| 61 | TESK1 | 0.71024852 |
| 62 | CAMK2B | 0.70721242 |
| 63 | PTK2 | 0.70217124 |
| 64 | CAMK1 | 0.67733703 |
| 65 | MAP2K4 | 0.67380583 |
| 66 | PRKACG | 0.66844943 |
| 67 | MAPK7 | 0.66297643 |
| 68 | GSK3A | 0.66059727 |
| 69 | LRRK2 | 0.65303911 |
| 70 | ACVR1B | 0.63466569 |
| 71 | RPS6KC1 | 0.63318526 |
| 72 | RPS6KL1 | 0.63318526 |
| 73 | TRIB3 | 0.61107756 |
| 74 | PRKACA | 0.60788635 |
| 75 | ROCK2 | 0.60762767 |
| 76 | ITK | 0.59232143 |
| 77 | FYN | 0.59205316 |
| 78 | SIK1 | 0.58798724 |
| 79 | EPHB1 | 0.58199043 |
| 80 | PBK | 0.56639219 |
| 81 | NTRK3 | 0.56405921 |
| 82 | PRKG1 | 0.56078292 |
| 83 | NLK | 0.54459781 |
| 84 | FER | 0.51418868 |
| 85 | AKT2 | 0.48751345 |
| 86 | MAP3K2 | 0.48273261 |
| 87 | PTK2B | 0.48099233 |
| 88 | SGK494 | 0.47933187 |
| 89 | SGK223 | 0.47933187 |
| 90 | MAPK12 | 0.47291192 |
| 91 | RPS6KA6 | 0.46562605 |
| 92 | CAMK1D | 0.45915902 |
| 93 | NTRK1 | 0.45840862 |
| 94 | STK38 | 0.44934655 |
| 95 | MAPKAPK2 | 0.43845649 |
| 96 | CDK19 | 0.42973816 |
| 97 | PTK6 | 0.42539136 |
| 98 | TAOK1 | 0.41969185 |
| 99 | MAP3K7 | 0.41790358 |
| 100 | TYRO3 | 0.41235219 |
| 101 | PKN1 | 0.40328558 |
| 102 | RPS6KA1 | 0.38459626 |
| 103 | MAP3K12 | 0.36309056 |
| 104 | PRKD1 | 0.36225269 |
| 105 | FGFR3 | 0.35977227 |
| 106 | INSRR | 0.35337911 |
| 107 | STK11 | 0.34906433 |
| 108 | MAPK13 | 0.34751333 |
| 109 | CAMK2A | 0.34133734 |
| 110 | RPS6KA3 | 0.33668559 |
| 111 | BMX | 0.33154446 |
| 112 | PRKG2 | 0.32546105 |
| 113 | BCKDK | 0.32208888 |
| 114 | PDPK1 | 0.31712835 |
| 115 | MARK3 | 0.30820723 |
| 116 | PRKCI | 0.30806217 |
| 117 | PRKACB | 0.30758432 |
| 118 | ERBB3 | 0.30056873 |
| 119 | PRKCH | 0.29121978 |
| 120 | SRC | 0.28737341 |
| 121 | SGK2 | 0.28654496 |
| 122 | STK38L | 0.27743840 |
| 123 | MAP3K3 | 0.26995628 |
| 124 | UHMK1 | 0.26952483 |
| 125 | DAPK2 | 0.26750487 |
| 126 | MST4 | 0.25702026 |
| 127 | SGK3 | 0.24962282 |
| 128 | WNK1 | 0.24228672 |
| 129 | ZAP70 | 0.23641456 |
| 130 | PKN2 | 0.23638110 |
| 131 | PDGFRB | 0.23437221 |
| 132 | PDK2 | 0.22975740 |
| 133 | FRK | 0.22893495 |
| 134 | MAPK4 | 0.22496139 |
| 135 | INSR | 0.21993518 |
| 136 | MAP2K1 | 0.21830037 |
| 137 | FES | 0.21318592 |
| 138 | PDK1 | 0.20846042 |
| 139 | MAP3K1 | 0.20687189 |
| 140 | LATS1 | 0.20372741 |
| 141 | MAPK11 | 0.18391167 |
| 142 | CCNB1 | 0.16849895 |
| 143 | PRKCA | 0.16777924 |
| 144 | FGFR4 | 0.14678918 |
| 145 | TNIK | 0.14320356 |
| 146 | SGK1 | 0.13866762 |
| 147 | ADRBK1 | 0.13772715 |
| 148 | MAPK10 | 0.13535103 |
| 149 | MAP2K6 | 0.11377088 |
| 150 | AKT1 | 0.08496912 |
| 151 | MAPK9 | 0.08329840 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.91950171 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.00971750 |
| 3 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.51241112 |
| 4 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 2.42214848 |
| 5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.34518089 |
| 6 | Bladder cancer_Homo sapiens_hsa05219 | 2.30653143 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.21265817 |
| 8 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.10040191 |
| 9 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.04529559 |
| 10 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.99835456 |
| 11 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.87307240 |
| 12 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.81389951 |
| 13 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.75828056 |
| 14 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.74753031 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.73124791 |
| 16 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.63753635 |
| 17 | Carbon metabolism_Homo sapiens_hsa01200 | 1.61366699 |
| 18 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.57456831 |
| 19 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.55756786 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.54273274 |
| 21 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.53051052 |
| 22 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.50885561 |
| 23 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.49210835 |
| 24 | Focal adhesion_Homo sapiens_hsa04510 | 1.46428828 |
| 25 | Circadian rhythm_Homo sapiens_hsa04710 | 1.44103829 |
| 26 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.42714838 |
| 27 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.41496327 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.40326270 |
| 29 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.32911824 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.26670896 |
| 31 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.21644110 |
| 32 | Tight junction_Homo sapiens_hsa04530 | 1.17811984 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.17414826 |
| 34 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.16883589 |
| 35 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16811247 |
| 36 | Platelet activation_Homo sapiens_hsa04611 | 1.14933069 |
| 37 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.14065449 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.11855879 |
| 39 | Insulin resistance_Homo sapiens_hsa04931 | 1.09594676 |
| 40 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.09029571 |
| 41 | Taste transduction_Homo sapiens_hsa04742 | 1.06687129 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.03111368 |
| 43 | Histidine metabolism_Homo sapiens_hsa00340 | 1.02780393 |
| 44 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.02168335 |
| 45 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.01459314 |
| 46 | GABAergic synapse_Homo sapiens_hsa04727 | 0.99895904 |
| 47 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.97763091 |
| 48 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.95612176 |
| 49 | Circadian entrainment_Homo sapiens_hsa04713 | 0.95402043 |
| 50 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.95247656 |
| 51 | Mineral absorption_Homo sapiens_hsa04978 | 0.94279302 |
| 52 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.93730163 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 0.92774311 |
| 54 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.91469468 |
| 55 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.90465369 |
| 56 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.90384787 |
| 57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89341825 |
| 58 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.89263398 |
| 59 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.88141831 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88134168 |
| 61 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.87243014 |
| 62 | Bile secretion_Homo sapiens_hsa04976 | 0.86759685 |
| 63 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.86055176 |
| 64 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.82849105 |
| 65 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.81694527 |
| 66 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.81661906 |
| 67 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.81397799 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80451883 |
| 69 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.79932261 |
| 70 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.79185206 |
| 71 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.78186680 |
| 72 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.76476750 |
| 73 | Axon guidance_Homo sapiens_hsa04360 | 0.76246192 |
| 74 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.75062220 |
| 75 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.74823863 |
| 76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.74278949 |
| 77 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.72875861 |
| 78 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.72053956 |
| 79 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.71929260 |
| 80 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.71643605 |
| 81 | Renin secretion_Homo sapiens_hsa04924 | 0.71497754 |
| 82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.71231098 |
| 83 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.70687725 |
| 84 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.70457463 |
| 85 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.67592097 |
| 86 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66386450 |
| 87 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.65314973 |
| 88 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.64695157 |
| 89 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.64560241 |
| 90 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.64509961 |
| 91 | Cocaine addiction_Homo sapiens_hsa05030 | 0.64264030 |
| 92 | Nicotine addiction_Homo sapiens_hsa05033 | 0.64227115 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.62286582 |
| 94 | Morphine addiction_Homo sapiens_hsa05032 | 0.62246196 |
| 95 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.61739697 |
| 96 | Melanogenesis_Homo sapiens_hsa04916 | 0.61599991 |
| 97 | Amoebiasis_Homo sapiens_hsa05146 | 0.60092959 |
| 98 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.59765249 |
| 99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.58182234 |
| 100 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57378197 |
| 101 | Gap junction_Homo sapiens_hsa04540 | 0.55995034 |
| 102 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.55631757 |
| 103 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.55113510 |
| 104 | Alzheimers disease_Homo sapiens_hsa05010 | 0.54970865 |
| 105 | Insulin secretion_Homo sapiens_hsa04911 | 0.54742737 |
| 106 | ABC transporters_Homo sapiens_hsa02010 | 0.53970106 |
| 107 | Parkinsons disease_Homo sapiens_hsa05012 | 0.52244388 |
| 108 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.52115195 |
| 109 | Salivary secretion_Homo sapiens_hsa04970 | 0.51173293 |
| 110 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50768860 |
| 111 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.49005447 |
| 112 | Salmonella infection_Homo sapiens_hsa05132 | 0.48094492 |
| 113 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.47609007 |
| 114 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46965853 |
| 115 | Peroxisome_Homo sapiens_hsa04146 | 0.46145925 |
| 116 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.45877634 |
| 117 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.45817509 |
| 118 | Huntingtons disease_Homo sapiens_hsa05016 | 0.45529337 |
| 119 | Phagosome_Homo sapiens_hsa04145 | 0.44721091 |
| 120 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44000835 |
| 121 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.43881179 |
| 122 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43652499 |
| 123 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.42820146 |
| 124 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.42581385 |
| 125 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.41049866 |
| 126 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40032608 |
| 127 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38769100 |
| 128 | Lysosome_Homo sapiens_hsa04142 | 0.38486736 |
| 129 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38154607 |
| 130 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.37518054 |
| 131 | Adherens junction_Homo sapiens_hsa04520 | 0.37470472 |
| 132 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.37327274 |
| 133 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.34902441 |
| 134 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.33913454 |
| 135 | Lysine degradation_Homo sapiens_hsa00310 | 0.30793436 |
| 136 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.29080274 |
| 137 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.28060264 |
| 138 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.25852578 |
| 139 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.24143585 |
| 140 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.23015958 |

